SUCAMPO PHARMACEUTICALS, INC. Notes Payable, Fair Value Disclosure
SUCAMPO PHARMACEUTICALS, INC. had Notes Payable, Fair Value Disclosure of $26.32 million as of 2014-12-31, per its 10-K filed 2015-03-09.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures
us-gaap:NotesPayableFairValueDisclosure · last filed 2015-03-09
- 2014-12-31: Notes Payable, Fair Value Disclosure $26.32M.
- 2014-09-30: Notes Payable, Fair Value Disclosure $49.26M.
- 2014-06-30: Notes Payable, Fair Value Disclosure $50.71M.
- 2014-03-31: Notes Payable, Fair Value Disclosure $54.34M.
| Period end | Notes Payable, Fair Value Disclosure |
|---|---|
| 2014-12-31 | $26.32M 10-K · filed 2015-03-09 |
| 2014-09-30 | $49.26M 10-Q · filed 2014-11-07 |
| 2014-06-30 | $50.71M 10-Q · filed 2014-08-06 |
| 2014-03-31 | $54.34M 10-Q · filed 2014-05-09 |
| 2013-12-31 | $53.90M 10-Q · filed 2014-11-07 |
| 2013-09-30 | $58.75M 10-Q · filed 2013-11-08 |
| 2013-06-30 | $58.55M 10-Q · filed 2013-08-09 |
| 2012-12-31 | $53.67M 10-Q · filed 2013-11-08 |